Saponin with immunoadjuvant function, preparation method, vaccine preparation containing the saponin as adjuvant and uses thereof

Abstract

The invention relates to a saponin with immune adjuvant function and a preparation method thereof, a vaccine preparation containing the saponin as an adjuvant, and applications of the saponin and the vaccine preparation in the prevention and treatment of infectious diseases and cancers of human and animals. The saponin is platycodin D, platycodin D2, or a total-saponin containing the two saponin compounds. The platycodin D and platycodin D2 are both extracted and separated from balloonflower, a Chinese medicine. The saponin can induce an organism to generate Th1-type and Th2-type immune responses, show the capability of inducing the organism to generate stronger cell immune response and humoral immune response to a vaccine than the alhydrogel adjuvant known in the prior art, and can be taken as the immune adjuvant for a plurality of vaccines and achieve an ideal immunity effect. The vaccine which takes the saponin as the adjuvant has simple preparation technology and simple and convenient method, and the quality is easy to control and the saponin can be reserved by freezing.

Description

technical field [0001] The present invention relates to saponin with immune adjuvant function, its preparation method, vaccine preparation containing the saponin as adjuvant, and their application in prevention and treatment of human and animal infectious diseases and cancer agents. Background technique [0002] Traditional vaccines are generally made of whole bacteria or whole viruses, and contain a large amount of non-immunogenic substances. These substances have certain adjuvant effects in addition to toxic and side effects, so generally do not need to add adjuvants [Lima KM, dos Santos SA , Rodrigues Jr JM, Silva CL. Vaccine adjuvant: it makes the difference. Vaccine 2004;22:2374-9]. With the continuous deepening of the basic theory of immunology and the rapid development of antigen purification technology and genetic engineering technology, many new vaccines such as gene vaccines, recombinant vaccines and synthetic peptide vaccines have emerged. These new vaccines have...

AI Technical Summary

Problems solved by technology

However, there are some problems with aluminum colloid adjuvant: ①Mainly through the induction of Th2 type immune response to produce antibodies to play a protective role, can not induce Th1 type immune response and cell-mediated immune response, only suitable for the main protective immunity of antibodies Vaccine; ②It has no adjuvant effect on various antigens such as human immunodeficiency virus, hepatitis C virus, herpes simplex virus, influenza virus, schistosomiasis, pertussis and typhoid fever; ③It can promote the production of IgE antibodies and easily induce allergic reactions in the body; ④ local reaction, granuloma will be formed, and local aseptic abscess may occur in very rare cases; ⑤ due to its physical and chemical properties, aluminum-containing glue vaccines are afraid of freezing, and aluminum glue is easy to denature after freezing; ⑥ may have harmful effects on the nervous system of humans and animals. influences

However, there are serious defects in Quil A: ① strong hemolysis, high toxicity and side effects, can cause local tissue necrosis, and even systemic adverse reactions and poisoning [Waite DC, Jacobson EW, Ennis FA, Edelman R, White B, Kammer R, et al .Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponinadjuvan

Images